Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allo HSCT Using RIC for Hematological Diseases

    ... cell infusion. The primary objective is to evaluate rates of acute graft-versus-host disease (GVHD) grades II-IV and chronic GVHD ... once they achieved a complete remission. Chronic Myelogenous Leukemia excluding refractory blast crisis: To be eligible ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  2. Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders (BMT)

    ... transplantation. This includes, but is not limited to: acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), chronic lymphocytic leukemia (CLL), non-Hodgkin ...

    Clinical Trial last updated 05/09/2016 - 3:36pm.

  3. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... from zero to 30% but are typically short lived. Acute Leukemias: Must be in remission by morphology (<5% blasts ... CR Natural killer cell malignancies Chronic myelogenous leukemia (CML): all types except refractory blast crisis. ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  4. Chemotherapy

    ... risk IPSS score, you have a higher risk of developing Acute Myelogenous Leukemia (AML). To prevent this from happening, your doctor may ...

    Page last updated 01/20/2015 - 4:45pm.

  5. Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

    ...

    Clinical Trial last updated 04/27/2016 - 1:19pm.

  6. Clinical Trials Report for December 2015

    ... transplantation will be given to patients with high risk acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). This ...

    Page last updated 11/30/2015 - 10:31am.

  7. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... the CD8+ memory T-cell infusion; patients with a history of acute GVHD overall grade II based on skin only involvement or upper ... therapy Acute leukemia not in remission Chronic myelogenous leukemia (CML) Active central nervous system (CNS) involvement ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.

  8. Overlap Syndromes: When PNH Appears with Aplastic Anemia or MDS

    ... who probably had PNH/MDS, where the MDS transformed to acute myelogenous leukemia . Then there’s the very rare PNH/MPN category, only ...

    Interview last updated 05/14/2015 - 1:53pm.

  9. Treatments

    ... risk IPSS score, you have a higher risk of developing Acute Myelogenous Leukemia (AML). To prevent this from happening, your doctor may ...

    Topic section last updated 03/30/2016 - 3:13pm.

  10. Ilene Galinsky BSN,MSN,ANP-C

    ... in the diagnosis, treatment, and management of patients with acute and chronic myelogenous leukemia (CML), myelodysplastic syndrome (MDS), myelofibrosis, and ...

    Bio last updated 03/11/2016 - 1:41pm.